[a phase iii study to evaluate safety and efficacy of fluticasone/formoterol combination (flutiform ® aerosol) in long-term administration (24 weeks) in japanese pediatric patients with bronchial asthma].

CONCLUSION: It was considered that FP/FM could be useful for long-term control of pediatric asthma.
PMID: 32684549 [PubMed - in process]

Source: Allergology International - July 21, 2020 Category: Allergy & Immunology Tags: Arerugi Source Type: research